Unlocking the potential of
genomic medicine

2017 News Releases

Date Title
Toggle Summary05/03/2016
PHILADELPHIA, PA -- (Marketwired) -- 05/03/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Michael Diem , MD as Senior Vice President of Corporate and Business Development. Dr. Diem will be a key member of the Medgenics leadership team, heading all business and corporate
Toggle Summary05/02/2016
PHILADELPHIA, PA -- (Marketwired) -- 05/02/16 -- Medgenics, Inc. (NYSE MKT: MDGN) will host a conference call and live audio webcast on Tuesday, May 10, 2016 at 8:30 a.m. EDT to discuss the financial results for the first quarter ended March 31, 2016 .
Toggle Summary04/20/2016
PHILADELPHIA, PA -- (Marketwired) -- 04/20/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Eric Phillips , MPH, ScD as Vice President of Regulatory Affairs. In this role, Dr. Phillips will be a key member of the Medgenics leadership team setting the strategy and tactics
Toggle Summary03/30/2016
PHILADELPHIA, PA -- (Marketwired) -- 03/30/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced that Brian Piper , Chief Financial Officer, will present at the 15 th Annual Needham Healthcare Conference in New York, NY . The event will take place on Wednesday April 13, 2016 at 10:00 a.m.
Toggle Summary03/08/2016
PHILADELPHIA, PA -- (Marketwired) -- 03/08/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Rick Couch , Ph.D., as Vice President of Chemistry, Manufacturing and Controls (CMC). In this role, Dr. Couch will be a key member in setting the strategy and tactics of technical
Toggle Summary02/17/2016
PHILADELPHIA, PA -- ( Marketwired ) -- 02/17/16 -- In the news release, "Medgenics Reports Fourth Quarter and Full Year 2015 Results and Advancement of NFC-1 Development Programs" issued earlier today by Medgenics Inc (NYSE MKT: MDGN), we are advised by the company that the weighted average number
Toggle Summary02/08/2016
PHILADELPHIA, PA -- ( Marketwired ) -- 02/08/16 -- Medgenics, Inc. (NYSE MKT: MDGN) will host a conference call and live audio webcast on Wednesday, February 17, 2016 at 8:30 a.m. ET to discuss fourth quarter and 2015 year end results. In order to participate in the conference call, please dial
Toggle Summary02/03/2016
PHILADELPHIA, PA -- ( Marketwired ) -- 02/03/16 -- Medgenics, Inc. (NYSE MKT: MDGN) today announced that Brian Piper will become the Company's new Chief Financial Officer effective February 9, 2016 . Mr. Piper joined Medgenics in April 2014 as Vice President of Finance and Investor Relations.
Toggle Summary01/26/2016
PHILADELPHIA , Jan. 26, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), today announced that members of its management team will participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day on Tuesday, February 2, 2016 in New York, NY . About Medgenics, Inc.
Toggle Summary01/06/2016
PHILADELPHIA , Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), today announced the signing of a license with Stanford University providing exclusive rights to certain breakthrough gene therapy technologies developed in the labs of Professor Mark A.